Evidence map›Paper›PMID 25126896›Full record

ArticleACS chemical biology2014

Labeled EF-Tus for rapid kinetic studies of pretranslocation complex formation.

Wei Liu, Darius Kavaliauskas, Jared M Schrader, Kiran Poruri, Victoria Birkedal, Emanuel Goldman, Hieronim Jakubowski, Wlodek Mandecki, Olke C Uhlenbeck, Charlotte R Knudsen and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS chemical biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Transcriptomics ofFrontiers in bioengineering and biotechnology · 2023
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Wei LiuDepartment of Chemistry and ‡Pennsylvania Muscle Institute, School of Medicine, University of Pennsylvania , Philadelphia, Pennsylvania 19104, United States.
Darius Kavaliauskas
Jared M Schrader
Kiran Poruri
Victoria Birkedal
Emanuel Goldman
Hieronim Jakubowski
Wlodek Mandecki
Olke C Uhlenbeck
Charlotte R Knudsen
Yale E Goldman
Barry S Cooperman
Rutgers, The State University of New Jersey · USAarhus University · DKNorthwestern University · US

Funding

Single Molecule Dynamics of mRNA TranslationR01GM080376 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI COOPERMAN, BARRY S., GOLDMAN, YALE E · 2008 to 2016
$2.5M
Ribosome-based Single Molecule Method to Acquire Sequence Data from GenomesR01HG004364 · NHGRI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI MANDECKI, WLODEK · 2007 to 2010
$1.9M
NHGRI NIH HHS HG004364NHGRI NIH HHS R01 HG004364NIGMS NIH HHS GM080376NIGMS NIH HHS R01 GM080376
6 · The paper itself

Abstract

The universally conserved translation elongation factor EF-Tu delivers aminoacyl(aa)-tRNA in the form of an aa-tRNA·EF-Tu·GTP ternary complex (TC) to the ribosome where it binds to the cognate mRNA codon within the ribosomal A-site, leading to formation of a pretranslocation (PRE) complex. Here we describe preparation of QSY9 and Cy5 derivatives of the variant E348C-EF-Tu that are functional in translation elongation. Together with fluorophore derivatives of aa-tRNA and of ribosomal protein L11, located within the GTPase associated center (GAC), these labeled EF-Tus allow development of two new FRET assays that permit the dynamics of distance changes between EF-Tu and both L11 (Tu-L11 assay) and aa-tRNA (Tu-tRNA assay) to be determined during the decoding process. We use these assays to examine: (i) the relative rates of EF-Tu movement away from the GAC and from aa-tRNA during decoding, (ii) the effects of the misreading-inducing antibiotics streptomycin and paromomycin on tRNA selection at the A-site, and (iii) how strengthening the binding of aa-tRNA to EF-Tu affects the rate of EF-Tu movement away from L11 on the ribosome. These FRET assays have the potential to be adapted for high throughput screening of ribosomal antibiotics.

Indexed as

Escherichia coliEscherichia coli ProteinsGuanosine TriphosphateKineticsModels, MolecularMutationPeptide Elongation Factor TuProtein BiosynthesisProtein ConformationRibosomal ProteinsRibosomesRNA, Transfer, Amino AcylEscherichia coli ProteinsGuanosine TriphosphatePeptide Elongation Factor Turibosomal protein L11Ribosomal ProteinsRNA, Transfer, Amino Acyl

Identifiers

PMID25126896
PMCPMC4201349
OpenAlexW2019264955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.